Document is current
Any future updates will be listed below
-
Authors
Guerzoni, Simona https://orcid.org/0000-0001-9589-2782
Pellesi, Lanfranco https://orcid.org/0000-0003-4137-5039
Giannessi, Lisa
Lo Castro, Flavia https://orcid.org/0000-0002-8572-3421
Olivieri, Maria Chiara
Degli Esposti, Luca
Gandolfi, Francesca
- License Information
-
More Information
Article History
Received: 21 April 2026
Accepted: 16 June 2026
First Online: 20 June 2026
Declarations
:
: The study was approved by the Area Vasta Emilia Nord Ethics Committee of Modena (protocol number: 125/2020/OSS/AOUMO) and conducted in accordance with the Declaration of Helsinki.
: Not applicable.
: Simona Guerzoni has received speaker honoraria and consulting fees from Teva, Eli Lilly/Organon, Abbvie, Pfizer, Organon and Lundbeck. Lanfranco Pellesi has received consulting fees from Eli Lilly and serves as an editorial board member; no involvement occurred in any review or editorial decision-making process related to this paper. Flavia Lo Castro has received speaker honoraria from Organon and AbbVie. The other authors report no competing interests in relation to this manuscript.
